-transparent.png){kind=logo}
Clinical and experimental studies show that tricyclic antidepressants in "therapeutic plasma concentrations" can increase heart rate, myocardial contractility and blood pressure. Our study was undertaken to analyze the role of beta-adrenergic stimulation in the chronotropic and inotropic effects of imipramine. Strips of rat right atrium including the sinus node, which were beating spontaneously, were used to study chronotropism. Strips of the left atrium, electrically stimulated to beat at 1 Hz, were used to study inotropism. The preparations were superfused in vitro with Tyrode's solution at 37 degrees C and exposed to imipramine while recording membrane potentials or force of contraction. Imipramine exerted dose-dependent biphasic actions. Imipramine 0.8 microM produced positive chronotropic and inotropic actions which were blocked by propranolol. Imipramine 1.6 microM depressed the sinus node automaticity, but it did not modify the force of contraction. Imipramine 3.2 microM depressed both the sinus node automaticity and the myocardial contractility. In conclusion, imipramine in "therapeutic plasma concentrations" produces beta-adrenergic mediated cardiac positive chronotropic and inotropic actions. The possible mechanisms of the depressant effects of imipramine itself on automaticity and contractility are still not clear. The results presented can explain stimulatory and depressant cardiac effects of therapeutic doses and overdoses of tricyclic antidepressants.
R P Salvatici, and
D J Standen, and
C S Shulz, and
M E Cabezas, and
C S Torres, and
R G Carpentier
January 1997,
Advances in experimental medicine and biology,
R P Salvatici, and
D J Standen, and
C S Shulz, and
M E Cabezas, and
C S Torres, and
R G Carpentier
May 1978,
The American journal of physiology,
R P Salvatici, and
D J Standen, and
C S Shulz, and
M E Cabezas, and
C S Torres, and
R G Carpentier
September 1973,
Archives internationales de pharmacodynamie et de therapie,
R P Salvatici, and
D J Standen, and
C S Shulz, and
M E Cabezas, and
C S Torres, and
R G Carpentier
April 1978,
Acta pharmacologica et toxicologica,
R P Salvatici, and
D J Standen, and
C S Shulz, and
M E Cabezas, and
C S Torres, and
R G Carpentier
January 1982,
Acta pharmacologica et toxicologica,
R P Salvatici, and
D J Standen, and
C S Shulz, and
M E Cabezas, and
C S Torres, and
R G Carpentier
August 1981,
Archives internationales de pharmacodynamie et de therapie,
R P Salvatici, and
D J Standen, and
C S Shulz, and
M E Cabezas, and
C S Torres, and
R G Carpentier
June 1983,
The Journal of clinical psychiatry,
R P Salvatici, and
D J Standen, and
C S Shulz, and
M E Cabezas, and
C S Torres, and
R G Carpentier
January 1992,
Uspekhi fiziologicheskikh nauk,
R P Salvatici, and
D J Standen, and
C S Shulz, and
M E Cabezas, and
C S Torres, and
R G Carpentier
December 1964,
Japanese journal of pharmacology,
R P Salvatici, and
D J Standen, and
C S Shulz, and
M E Cabezas, and
C S Torres, and
R G Carpentier
October 2006,
Proceedings of the National Academy of Sciences of the United States of America,
